文献速递妇科

晚期卵巢癌患者管理中的多学科方法:一种个体化方法——来自专科卵巢癌中心的结果

Multidisciplinary approach in the management of advanced ovarian cancer patients: A personalized approach. Results from a specialized ovarian cancer unit.
PubMed 文献 · Gynecol Oncol · 2017-01-20

该研究纳入2009至2012年间转诊至本机构的363例晚期卵巢癌患者,全部接受初次多学科评估,并据此分流至直接新辅助化疗后间隔手术(A组)、手术探查后原发减瘤(B组)或新辅助化疗(C组)。三组总生存期分别为34、59、29个月(P<0.001),无进展生存期分别为10、21、12个月(P<0.001)。作者认为多学科方法可基于患者特征与肿瘤扩散程度优化治疗策略。

要点

  • 363例晚期卵巢癌患者全部接受初次多学科评估,据此分流至不同治疗策略。
  • A组38例(10.5%)直接接受新辅助化疗后间隔手术,其中24例(63%)有膈上/多发肝转移。
  • B组295例(91%)接受原发减瘤手术,200例(68%)达无肉眼残留,77例(26%)残留<5mm。

核心结论

  • 对转诊至三级中心的晚期卵巢癌患者采用多学科方法,可基于患者特征(年龄、体能/营养状态、合并症、功能状态)和肿瘤扩散程度(术前和术中评估)优化治疗策略。

研究设计与样本

  • 研究纳入2009至2012年间转诊至本机构的晚期卵巢癌患者,全部进行初次多学科评估。
  • 根据评估结果将患者分流至:A组接受初次新辅助化疗后间隔手术;B组手术探查后接受原发减瘤;C组手术探查后接受新辅助化疗。

主要发现

  • 共纳入363例患者,A组38例(10.5%),其中24例(63%)有膈上/多发肝转移,14例(37%)因麻醉/内科原因排除原发减瘤。
  • 325例(89.5%)考虑手术探查,其中295例(91%;B组)接受以减瘤为目的的原发手术(N:277),200例(68%)达无肉眼残留(R0),77例(26%)残留<5mm(R1),18例(6%)为姑息意图。
  • 30例(9%;C组)转诊接受新辅助化疗,其中27例(90%)接受间隔手术,3例出现疾病进展。
  • 总生存期:A组34个月,B组59个月,C组29个月,P<0.001;无进展生存期:A组10个月,B组21个月,C组12个月,P<0.001。

临床怎么用

  • 原文结论认为,对转诊至三级中心的晚期卵巢癌患者采用多学科方法可优化治疗策略,依据为患者特征和肿瘤扩散程度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of the present study was to evaluate the impact of a multidisciplinary approach in patients' selection with advanced ovarian cancer (AOC) for different therapeutic strategies. METHODS: Patients referred at our institution between 2009 and 2012 for AOC were included. Primary multidisciplinary evaluation was performed in all patients. Different strategies included: 1. patients referred to primary neoadjuvant chemotherapy (NACT) and interval surgery (IDS) (group A); 2. patients considered for surgical exploration. After surgical exploration, patients were either considered for primary debulking (PDS; group B), or NACT (group C). RESULTS: A total of 363 patients were included. Of 38 patients (10.5%) in group A, 24 (63%) had sovradiaphragmatic/multiple liver metastases; 14 (37%) were excluded for PDS for anestehesiologic/medical reasons. Of 325 (89.5%) considered for surgical exploration, 295 (91%; group B) had primary surgery with debulking intent (N: 277) and were cytoreduced to no macroscopic disease (R0: N:200; 68%) o minimal RD<5mm (R1: N:77; 26%) or palliative intent (N:18; 6%); 30 (9%; group C) were referred for NACT. Of those, 27 (90%) underwent IDS, 3 had progressive disease. Overall survival (OS) and progression free survival (PFS) was different between the groups: OS: Group A: 34months; Group B: 59months; Group C: 29months; p<0.001. PFS: Group A: 10months; Group B; 21months; Group C: 12months; p<0.001. CONCLUSIONS: A multidisciplinary approach to patients referred to a tertiary center with AOC allows optimization of the treatment strategy, based on patients' characteristics (age, performance/nutritional status, comorbidities, functional status) and tumor diffusion (evaluated pre- and intraoperatively).

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Aletti GD, Garbi A, Messori P, et al. Multidisciplinary approach in the management of advanced ovarian cancer patients: A personalized approach. Results from a specialized ovarian cancer unit. Gynecol Oncol. 2017. PMID: 28117100. doi:10.1016/j.ygyno.2017.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。